CLINICAL_TRIALS
withdrawal
· 2025-01-31
Clinical Trial Update: Tranexamic Acid in Vaginal Reconstructive Surgery [Phase 4]
Summary
A Phase 4 clinical trial evaluating tranexamic acid in vaginal reconstructive surgery for pelvic organ prolapse has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The University of Texas Medical Branch, Galveston | Conditions: Pelvic Organ Prolapse | Phase 4 | Status: WITHDRAWN